Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Virus Research
|
June 5, 2012
Biochemical characterization of the small hydrophobic protein of avian metapneumovirus
Qiji Deng, Minxun Song, Andrew Demers, et al.
Virus Research
|
November 30, 2004
Comparison of the full-length genome sequence of avian metapneumovirus subtype C with other paramyxoviruses
Humphrey C M Lwamba, Rene Alvarez, Mark G Wise, et al.
Technology in Cancer Research & Treatment
|
July 4, 2013
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy
Yunzhou Wu, Shijun Yan, Zheng Lv, et al.
European Journal of Pharmacology
|
March 2, 2017
Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
Yunzhou Wu, Jinjiao He, Jingshu Geng, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
December 17, 2014
Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines
Stivalis Cardenas-Garcia, Diego G Diel, Leonardo Susta, et al.
Scientific Reports
|
March 4, 2016
Molecular basis for the thermostability of Newcastle disease virus
Guoyuan Wen, Xiao Hu, Kang Zhao, et al.
Veterinary Microbiology
|
March 2, 2005
Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strains
Bruce S Seal, Mark G Wise, Janice C Pedersen, et al.
Journal of Virology
|
August 15, 2014
Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain
Jing Sun, Yongwei Wei, Abdul Rauf, et al.
Journal of Pharmacological Sciences
|
May 14, 2016
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Yunzhou Wu, Jinjiao He, Ying An, et al.
Technology in Cancer Research & Treatment
|
March 21, 2014
Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
Zeshan Niu, Fuliang Bai, Tian Sun, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Virus Research
|
June 5, 2012
Biochemical characterization of the small hydrophobic protein of avian metapneumovirus
Qiji Deng, Minxun Song, Andrew Demers, et al.
Virus Research
|
November 30, 2004
Comparison of the full-length genome sequence of avian metapneumovirus subtype C with other paramyxoviruses
Humphrey C M Lwamba, Rene Alvarez, Mark G Wise, et al.
Technology in Cancer Research & Treatment
|
July 4, 2013
Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy
Yunzhou Wu, Shijun Yan, Zheng Lv, et al.
European Journal of Pharmacology
|
March 2, 2017
Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy
Yunzhou Wu, Jinjiao He, Jingshu Geng, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
December 17, 2014
Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines
Stivalis Cardenas-Garcia, Diego G Diel, Leonardo Susta, et al.
Scientific Reports
|
March 4, 2016
Molecular basis for the thermostability of Newcastle disease virus
Guoyuan Wen, Xiao Hu, Kang Zhao, et al.
Veterinary Microbiology
|
March 2, 2005
Genomic sequences of low-virulence avian paramyxovirus-1 (Newcastle disease virus) isolates obtained from live-bird markets in North America not related to commonly utilized commercial vaccine strains
Bruce S Seal, Mark G Wise, Janice C Pedersen, et al.
Journal of Virology
|
August 15, 2014
Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain
Jing Sun, Yongwei Wei, Abdul Rauf, et al.
Journal of Pharmacological Sciences
|
May 14, 2016
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
Yunzhou Wu, Jinjiao He, Ying An, et al.
Technology in Cancer Research & Treatment
|
March 21, 2014
Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
Zeshan Niu, Fuliang Bai, Tian Sun, et al.
Page
of 6